Statistics for Nuvectis Pharma, (id:5475 NVCT)

Valuation metrics

Market cap

212.14M

Enterprise value

194.98M

Trailing P/E (ttm)

-3.57

Forward P/E

-11.44

PEG ratio

-11.44

Price/Sales (ttm)

Price/Book (mrq)

18.96

Enterprise Value/Revenue

Enterprise Value/EBITDA

-8.52

Overview

Shares outstanding

19.32M

Float

6.80M

Shares short

1.13M

% Held by insiders

0.51%

% Held by institutions

0.08%

Average volume (10 days)

229.26K

Average volume (90 days)

Price summary

52-Week low

4.61

52-Week high

12.10

52-Week change

-60.78%

Beta

0.40

50-Day moving average

7.08

200-Day moving average

7.21

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

0.00%

Operating margin

0.00%

Operational effectiveness

Return on assets

-60.86%

Return on equity

-140.00%

Income statement

Revenue (ttm)

0.00

Revenue per share (ttm)

0.00

Quarterly revenue growth (yoy)

Gross profit (ttm)

0.00

EBITDA

0.00

Net income to common (ttm)

-19,374,000.00

Diluted EPS (ttm)

-1.16

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

17.17M

Total cash per share (mrq)

0.89

Total debt (mrq)

0.00

Total Debt/Equity (mrq)

0.00

Current ratio (mrq)

274.00%

Book value per share (mrq)

0.58

Cash flow

Cash flow statement

-13,632,000.00

Levered free cash flow (LFCF)

-6,313,000.00